| NCT03361163 |
Controlled Human Infection for Vaccination Against Streptococcus Pyogenes |
https://ClinicalTrials.gov/show/NCT03361163 |
Completed |
Murdoch Childrens Research Institute |
2019-09-28 |
| NCT03171350 |
Performance of Ellume·Lab Group A Strep Test Versus Culture for the Rapid Detection of Group A Streptococcus in Patients With Acute Pharyngitis. |
https://ClinicalTrials.gov/show/NCT03171350 |
Completed |
Ellume Pty Ltd |
2018-08-15 |
| NCT03170609 |
A Phase 1/2, Randomized, Placebo-controlled, Observer-blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Adults 18 To 49 Years Of Age |
https://ClinicalTrials.gov/show/NCT03170609 |
Completed |
Pfizer |
2018-06-25 |
| NCT02972281 |
Systematic Search for Primary Immunodeficiency in Adults With Infections |
https://ClinicalTrials.gov/show/NCT02972281 |
Recruiting |
University Hospital, Lille |
2020-03-31 |
| NCT02838407 |
Identification and Characterization of Bacteria in the Lungs of Children From 6 Months up to 6 Years Old, With Suspected Infection of the Lungs, in Spain. |
https://ClinicalTrials.gov/show/NCT02838407 |
Completed |
GlaxoSmithKline |
2015-09-23 |
| NCT02718157 |
Validation of the GenePOC GBS Assay for the Detection of the Cfb Gene From Streptococcus Agalactiae Strains |
https://ClinicalTrials.gov/show/NCT02718157 |
Completed |
GenePOC |
2017-02-07 |
| NCT02528981 |
Effect of Probiotics on GBS Colonization Status During Pregnancy: A Pilot Randomized Controlled Trial |
https://ClinicalTrials.gov/show/NCT02528981 |
Completed |
Ryerson University |
2016-06-30 |
| NCT02447432 |
A Study to Compare the Immunogenicity of GSK Biologicals’ 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorixâ„¢ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants |
https://ClinicalTrials.gov/show/NCT02447432 |
Completed |
GlaxoSmithKline |
2016-01-23 |
| NCT02270944 |
Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine |
https://ClinicalTrials.gov/show/NCT02270944 |
Completed |
GlaxoSmithKline |
2015-04-23 |
| NCT02142933 |
Simplified GBS Screening and Prevalence of ESBL in Pregnant Women |
https://ClinicalTrials.gov/show/NCT02142933 |
Completed |
University Hospital, Basel, Switzerland |
2016-11-30 |
| NCT02052973 |
Efficacy of Propolis Varnish Against Oral Biofilm |
https://ClinicalTrials.gov/show/NCT02052973 |
Completed |
Federal University of Minas Gerais |
2015-01-31 |
| NCT01979588 |
How Does the Clinical Tool ‘What’s Going Around’ Affect Clinical Practice |
https://ClinicalTrials.gov/show/NCT01979588 |
Completed |
NorthShore University HealthSystem |
2014-11-30 |
| NCT01746108 |
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals’ Pneumococcal Vaccine (Synflorixâ„¢) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection |
https://ClinicalTrials.gov/show/NCT01746108 |
Completed |
GlaxoSmithKline |
2015-06-29 |
| NCT01641133 |
Primary Vaccination With Either Synflorixâ„¢ or Prevenar 13â„¢ or Both Vaccines and Booster Vaccination With Synflorixâ„¢ |
https://ClinicalTrials.gov/show/NCT01641133 |
Completed |
GlaxoSmithKline |
2013-07-15 |
| NCT01616459 |
Immunogenicity and Safety of Two Formulations of GSK Biologicals’ Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants |
https://ClinicalTrials.gov/show/NCT01616459 |
Completed |
GlaxoSmithKline |
2013-04-25 |
| NCT01577108 |
Oral Probiotics Reduce Group B Streptococci Colonization in Pregnant Women |
https://ClinicalTrials.gov/show/NCT01577108 |
Completed |
China Medical University Hospital |
2012-09-30 |
| NCT01545375 |
Evaluation of a Vaccine for Reducing Ear and Lung Infections in Children |
https://ClinicalTrials.gov/show/NCT01545375 |
Completed |
GlaxoSmithKline |
2016-07-26 |
| NCT01485406 |
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals’ Pneumococcal Vaccine 2830930A Administered in Toddlers |
https://ClinicalTrials.gov/show/NCT01485406 |
Completed |
GlaxoSmithKline |
2012-03-15 |
| NCT03348618 |
A Study to Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) |
https://ClinicalTrials.gov/show/NCT03348618 |
Active, not recruiting |
IMMUNOe Research Centers |
2019-11-30 |
| NCT01446289 |
Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings |
https://ClinicalTrials.gov/show/NCT01446289 |
Completed |
Novartis |
2013-04-30 |
| NCT01412801 |
Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings |
https://ClinicalTrials.gov/show/NCT01412801 |
Completed |
Novartis |
2012-10-31 |
| NCT04100772 |
Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above |
https://ClinicalTrials.gov/show/NCT04100772 |
Recruiting |
CanSino Biologics Inc. |
2020-10-01 |
| NCT03807245 |
Group B Streptococcus Vaccine in Healthy Females |
https://ClinicalTrials.gov/show/NCT03807245 |
Completed |
Minervax ApS |
2019-10-14 |
| NCT03765073 |
Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Nonpregnant Women And Pregnant Women And Their Infants |
https://ClinicalTrials.gov/show/NCT03765073 |
Recruiting |
Pfizer |
2022-05-31 |
| NCT03669094 |
Effect of a New Probiotic Strain in the Reduction of Group B Streptococcus Colonization in Pregnant Women |
https://ClinicalTrials.gov/show/NCT03669094 |
Recruiting |
ProbiSearch SL |
2020-09-30 |
| NCT01262872 |
Impact of GSK Biologicals’ 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & Infants |
https://ClinicalTrials.gov/show/NCT01262872 |
Completed |
GlaxoSmithKline |
2013-03-18 |
| NCT01235949 |
Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A and Prophylactic Antipyretic Treatment |
https://ClinicalTrials.gov/show/NCT01235949 |
Completed |
GlaxoSmithKline |
2012-03-28 |
| NCT01204658 |
Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants |
https://ClinicalTrials.gov/show/NCT01204658 |
Completed |
GlaxoSmithKline |
2011-11-03 |
| NCT01193920 |
Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non Pregnant and Pregnant Women 18-40 Years of Age |
https://ClinicalTrials.gov/show/NCT01193920 |
Completed |
Novartis |
2011-12-31 |
| NCT01175083 |
Immunization of Children Between 8 Weeks and 2 Years of Age With GSK Pneumococcal Vaccine GSK1024850A |
https://ClinicalTrials.gov/show/NCT01175083 |
Completed |
GlaxoSmithKline |
2013-01-17 |
| NCT01156740 |
Treatment of Group A Beta Hemolytic Streptococcal Pharyngitis in Children in Low Resource Settings |
https://ClinicalTrials.gov/show/NCT01156740 |
Completed |
Johns Hopkins University |
2003-04-30 |
| NCT01153893 |
Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria |
https://ClinicalTrials.gov/show/NCT01153893 |
Completed |
GlaxoSmithKline |
2011-02-16 |
| NCT01153841 |
Primary Vaccination Study With GSK Biologicals’ Pneumococcal Vaccine in Healthy Infants in Vietnam |
https://ClinicalTrials.gov/show/NCT01153841 |
Completed |
GlaxoSmithKline |
2011-07-26 |
| NCT01119625 |
Immunological Persistence After Priming With GSK1024850A Vaccine and Safety& Immunogenicity After Booster Dose |
https://ClinicalTrials.gov/show/NCT01119625 |
Completed |
GlaxoSmithKline |
2011-02-17 |
| NCT01118143 |
Oral Health Literacy Tailored Communication |
https://ClinicalTrials.gov/show/NCT01118143 |
Completed |
University of Tromso |
2012-02-29 |
| NCT01030822 |
Booster and Catch-up Vaccination With Vaccine GSK1024850A |
https://ClinicalTrials.gov/show/NCT01030822 |
Completed |
GlaxoSmithKline |
2011-08-19 |
| NCT01030731 |
Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease |
https://ClinicalTrials.gov/show/NCT01030731 |
Completed |
Basilea Pharmaceutica |
2007-08-31 |
| NCT01027845 |
Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A in Healthy Japanese Children |
https://ClinicalTrials.gov/show/NCT01027845 |
Completed |
GlaxoSmithKline |
2010-08-13 |
| NCT01026740 |
Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT01026740 |
Completed |
Basilea Pharmaceutica |
2007-09-30 |
| NCT01026636 |
A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age |
https://ClinicalTrials.gov/show/NCT01026636 |
Completed |
Basilea Pharmaceutica |
2010-04-30 |
| NCT01026558 |
A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients |
https://ClinicalTrials.gov/show/NCT01026558 |
Completed |
Basilea Pharmaceutica |
2007-11-30 |
| NCT00985751 |
Safety & Immunogenicity of Pneumococcal Vaccine 2189242A in Children Aged 12-23 Months at the Time of First Vaccination |
https://ClinicalTrials.gov/show/NCT00985751 |
Completed |
GlaxoSmithKline |
2010-10-12 |
| NCT00985465 |
Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Mali |
https://ClinicalTrials.gov/show/NCT00985465 |
Completed |
GlaxoSmithKline |
2010-06-26 |
| NCT00950833 |
Long-term Follow-up Study of Children Previously Primed With GSK Pneumococcal Vaccine (GSK1024850A) and of Unprimed Children |
https://ClinicalTrials.gov/show/NCT00950833 |
Completed |
GlaxoSmithKline |
2010-09-16 |
| NCT00911144 |
Booster Vaccination Study With a Pneumococcal Vaccine in Children Primed With the Same Vaccine |
https://ClinicalTrials.gov/show/NCT00911144 |
Completed |
GlaxoSmithKline |
2010-01-11 |
| NCT00907777 |
Vaccination With GSK 1024850A in Children Primed With GSK 1024850A & Boosted With Pneumovax 23â„¢ |
https://ClinicalTrials.gov/show/NCT00907777 |
Completed |
GlaxoSmithKline |
2009-10-05 |
| NCT00896064 |
Evaluation of a Booster Dose of Pneumococcal Vaccine Formulations in Young Adults |
https://ClinicalTrials.gov/show/NCT00896064 |
Completed |
GlaxoSmithKline |
2009-08-05 |
| NCT00861380 |
Evaluation of Effectiveness of GSK Biologicals’ Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease |
https://ClinicalTrials.gov/show/NCT00861380 |
Completed |
GlaxoSmithKline |
2012-01-31 |
| NCT00839254 |
Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals’ Pneumococcal Conjugate Vaccine 1024850A |
https://ClinicalTrials.gov/show/NCT00839254 |
Completed |
GlaxoSmithKline |
2012-01-31 |
| NCT00829010 |
Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age. |
https://ClinicalTrials.gov/show/NCT00829010 |
Completed |
GlaxoSmithKline |
2011-06-13 |
| NCT00814710 |
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age |
https://ClinicalTrials.gov/show/NCT00814710 |
Completed |
GlaxoSmithKline |
2009-11-13 |
| NCT00808444 |
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age |
https://ClinicalTrials.gov/show/NCT00808444 |
Completed |
GlaxoSmithKline |
2009-11-02 |
| NCT00792909 |
Vaccination Course in Primed Children and Age-matched Unprimed Children With Pneumococcal Vaccine GSK1024850A |
https://ClinicalTrials.gov/show/NCT00792909 |
Completed |
GlaxoSmithKline |
2009-07-02 |
| NCT00756067 |
Evaluation of Pneumococcal Vaccine Formulations in Elderly |
https://ClinicalTrials.gov/show/NCT00756067 |
Completed |
GlaxoSmithKline |
2009-05-28 |
| NCT00707798 |
Evaluation of Pneumococcal Vaccine Formulations in Young Adults |
https://ClinicalTrials.gov/show/NCT00707798 |
Completed |
GlaxoSmithKline |
2009-01-15 |
| NCT00680914 |
Primary Vaccination Course in Children Receiving Pneumococcal Conjugate Vaccine GSK 1024850A or Prevenarâ„¢ and Hiberixâ„¢ |
https://ClinicalTrials.gov/show/NCT00680914 |
Completed |
GlaxoSmithKline |
2009-05-08 |
| NCT00678301 |
Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrixâ„¢ Hib and Polio Sabinâ„¢ |
https://ClinicalTrials.gov/show/NCT00678301 |
Completed |
GlaxoSmithKline |
2009-11-09 |
| NCT00652951 |
Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib |
https://ClinicalTrials.gov/show/NCT00652951 |
Completed |
GlaxoSmithKline |
2009-05-12 |
| NCT00646958 |
Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections |
https://ClinicalTrials.gov/show/NCT00646958 |
Completed |
Melinta Therapeutics, Inc. |
2008-04-30 |
| NCT00624819 |
Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate Vaccine |
https://ClinicalTrials.gov/show/NCT00624819 |
Completed |
GlaxoSmithKline |
2008-06-02 |
| NCT00609492 |
Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants. |
https://ClinicalTrials.gov/show/NCT00609492 |
Completed |
GlaxoSmithKline |
2008-11-10 |
| NCT00547248 |
Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines |
https://ClinicalTrials.gov/show/NCT00547248 |
Completed |
GlaxoSmithKline |
2008-05-10 |
| NCT00527852 |
Assessment of Flocked Swabs for the Identification of Group A Streptococcal Pharyngitis |
https://ClinicalTrials.gov/show/NCT00527852 |
Completed |
Children’s Hospital of Eastern Ontario |
2007-12-31 |
| NCT00514527 |
A Study for Patients With Complicated Skin and Skin Structure Infections |
https://ClinicalTrials.gov/show/NCT00514527 |
Completed |
Targanta Therapeutics Corporation |
2008-04-30 |
| NCT00513409 |
Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule |
https://ClinicalTrials.gov/show/NCT00513409 |
Completed |
GlaxoSmithKline |
2008-02-20 |
| NCT00496015 |
Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A |
https://ClinicalTrials.gov/show/NCT00496015 |
Completed |
GlaxoSmithKline |
2008-03-25 |
| NCT00489554 |
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age |
https://ClinicalTrials.gov/show/NCT00489554 |
Completed |
GlaxoSmithKline |
2008-03-31 |
| NCT00466947 |
COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate Vaccine |
https://ClinicalTrials.gov/show/NCT00466947 |
Completed |
GlaxoSmithKline |
2010-08-31 |
| NCT00390910 |
Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine in Preterm Infants |
https://ClinicalTrials.gov/show/NCT00390910 |
Completed |
GlaxoSmithKline |
2007-07-02 |
| NCT00370396 |
Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals’ 10-valent Pneumococcal Conjugate Vaccine. |
https://ClinicalTrials.gov/show/NCT00370396 |
Completed |
GlaxoSmithKline |
2007-06-04 |
| NCT00370227 |
Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals’ 10-valent Pneumococcal Conjugate Vaccine |
https://ClinicalTrials.gov/show/NCT00370227 |
Completed |
GlaxoSmithKline |
NA |
| NCT00345358 |
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals’ 10-valent Pneumococcal Conjugate Vaccine |
https://ClinicalTrials.gov/show/NCT00345358 |
Completed |
GlaxoSmithKline |
2007-11-15 |
| NCT00344318 |
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals’ 10-valent Pneumococcal Conjugate Vaccine |
https://ClinicalTrials.gov/show/NCT00344318 |
Completed |
GlaxoSmithKline |
2007-04-27 |
| NCT00334334 |
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals’ 10-valent Pneumococcal Conjugate Vaccine. |
https://ClinicalTrials.gov/show/NCT00334334 |
Completed |
GlaxoSmithKline |
2007-07-31 |
| NCT00333450 |
Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines. |
https://ClinicalTrials.gov/show/NCT00333450 |
Completed |
GlaxoSmithKline |
NA |
| NCT00327665 |
Study to Evaluate the Safety and Immunogenicity of an Investigational Pneumococcal Vaccine in the Elderly Population |
https://ClinicalTrials.gov/show/NCT00327665 |
Completed |
GlaxoSmithKline |
2007-01-01 |
| NCT00307554 |
A Lot-to-lot Consistency (3 Lots of GSK Biologicals’ 10-valent Pneumococcal Conjugate Vaccine) & Non-inferiority Study |
https://ClinicalTrials.gov/show/NCT00307554 |
Completed |
GlaxoSmithKline |
NA |
| NCT00307541 |
Assess the Immunogenicity of GSK Biologicals’ 10-valent Pneumococcal Conjugate Vaccine |
https://ClinicalTrials.gov/show/NCT00307541 |
Completed |
GlaxoSmithKline |
2006-04-07 |
| NCT00307034 |
Safety & Immunogenicity Study of 10-Valent Pneumococcal Conjugate Vaccine When Administered as a 2-Dose Schedule |
https://ClinicalTrials.gov/show/NCT00307034 |
Completed |
GlaxoSmithKline |
2007-01-01 |
| NCT00169481 |
A Study in Children With Different Formulations of GSK Biologicals’ 11 Valent Pneumococcal Conjugate Vaccine |
https://ClinicalTrials.gov/show/NCT00169481 |
Completed |
GlaxoSmithKline |
2005-05-31 |
| NCT00138112 |
Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation |
https://ClinicalTrials.gov/show/NCT00138112 |
Completed |
Memorial Sloan Kettering Cancer Center |
NA |
| NCT00128219 |
Prevention of GBS Colonization Via Immunity |
https://ClinicalTrials.gov/show/NCT00128219 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2008-12-31 |
| NCT00001658 |
Amoxicillin for the Treatment of Pediatric Autoimmune Disorders Associated With Streptococcal Infections |
https://ClinicalTrials.gov/show/NCT00001658 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001359 |
Preventive Measures for Childhood-Onset Obsessive-Compulsive Disorder and Tic Disorders (PANDAS Subgroup) |
https://ClinicalTrials.gov/show/NCT00001359 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |